Samlyn Capital »

Mineralys Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $47M 1.3M 36.29

More positions owned by Samlyn Capital

Lpl Financial Holdings (LPLA)
Bank of America Corporation (BAC)
Capital One Financial (COF)
Microsoft Corporation (MSFT)
Morgan Stanley Com New (MS)
First Solar (FSLR)
JPMorgan Chase & Co. (JPM)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Core & Main Cl A (CNM)
NVIDIA Corporation (NVDA)
Rb Global (RBA)
Spotify Technology S A SHS (SPOT)
Meta Platforms Cl A (META)
MercadoLibre (MELI)
Asml Holding N V N Y Registry Shs (ASML)

View all positions for Samlyn Capital

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
FMR
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management
Suvretta Capital Management

View all funds holding Mineralys Therapeutics